BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36964538)

  • 21. Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study.
    Li JX; Deng WX; Huang ST; Lin XF; Long MY; Zhang J; Su TS; Li LQ; Pang YD; Liang CF; Zhou HM; Lu HY; Liang SX; Xiang BD
    Radiat Oncol; 2022 Jun; 17(1):106. PubMed ID: 35690773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study.
    Fu Z; Li X; Zhong J; Chen X; Cao K; Ding N; Liu L; Zhang X; Zhai J; Qu Z
    Hepatol Int; 2021 Jun; 15(3):663-675. PubMed ID: 33877527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Cai M; Huang W; Huang J; Shi W; Guo Y; Liang L; Zhou J; Lin L; Cao B; Chen Y; Zhou J; Zhu K
    Front Immunol; 2022; 13():848387. PubMed ID: 35300325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
    Tang C; Shen J; Feng W; Bao Y; Dong X; Dai Y; Zheng Y; Zhang J
    Medicine (Baltimore); 2016 May; 95(20):e3754. PubMed ID: 27196501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study.
    Lu H; Zheng C; Liang B; Xiong B
    Anticancer Agents Med Chem; 2023; 23(4):461-469. PubMed ID: 35652401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma.
    Zhao H; Zhai X; Chen Z; Wan X; Chen L; Shen F; Ling C
    Oncotarget; 2017 Jul; 8(28):45234-45241. PubMed ID: 28423370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone.
    Hassanin TM; Fouad Y; Hassnine A; Eisawy M; Farag N; Abdel Ghany W
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1255-1261. PubMed ID: 33906320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM; Lai CX; Zuo MX; An C; Wang XC; Huang JH; Ning E
    J Cancer Res Ther; 2020; 16(7):1603-1610. PubMed ID: 33565506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
    Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma.
    Zhang S; Zhao Y; He L; Bo C; An Y; Li N; Ma W; Guo Y; Guo Y; Zhang C
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101851. PubMed ID: 34923180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
    Chen L; Kan X; Sun T; Ren Y; Cao Y; Yan L; Liang B; Xiong B; Zheng C
    BMC Gastroenterol; 2020 Jun; 20(1):205. PubMed ID: 32600349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Sorafenib Combined With Immunotherapy Following Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma: A Propensity Score Analysis.
    Qin J; Huang Y; Zhou H; Yi S
    Front Oncol; 2022; 12():807102. PubMed ID: 35463356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
    Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus.
    Zhang W; Wu L; Chen L; Sun T; Ren Y; Sun B; Zhu L; Han P; Zheng C
    Sci Rep; 2022 Apr; 12(1):5725. PubMed ID: 35388064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).
    Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L;
    Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with irinotecan-eluting beads: analysis of efficacy and safety.
    Liu D; Wang J; Ma Z; Zhang N; Zhao Y; Yang X; Wen Z; Xie H
    Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1092-1101. PubMed ID: 35588011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Huo YR; Eslick GD
    JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant radiotherapy and transarterial chemoembolization reduce skeletal-related events related to bone metastases from renal cell carcinoma.
    Heianna J; Makino W; Ariga T; Ishikawa K; Kusada T; Maemoto H; Toguchi M; Ito J; Goya M; Miyazato M; Iraha Y; Murayama S
    Eur Radiol; 2020 Mar; 30(3):1525-1533. PubMed ID: 31728686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.